comparison of glp 1 drugs Mapping the effectiveness and risks GLP-1 receptor agonists Metabolic Axis Comparative efficacy and safety of
Description
306 , G622G630 (2014)
In wildtype but not GLP-1R KO mice, liraglutide stimulates the secretion of natriuretic peptide (ANP) from the atrial cardiomyocytes and liraglutide fails to affect natriuresis and vasorelaxation in mice deficient for ANP [640]
Together, these modifications improve bioavailability and decelerate renal clearance [900]
larger trials are ongoing investigating retatrutide for people with type 2 diabetes, non-alcoholic fatty liver disease, and obesity
15.3.1 TERNS PHARMACEUTICALS, INC
iScience 24 , 103382 (2021)
